Skip to main content
logo
Latigo Biotherapeutics, Inc. (LTGO)
NASDAQ: LTGO · Real-Time Price · USD
20.06
+0.68 (3.51%)
At close: Aug 13, 2026, 4:00 PM EDT
20.01
-0.05 (-0.25%)
After-hours: Aug 13, 2026, 7:34 PM EDT

Latigo Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Aug '26 Dec '25 Dec '24
Market Capitalization
1,269--
Market Cap Growth
---
Enterprise Value
1,227--
Debt / Equity Ratio
0.020.010.11
Net Debt / Equity Ratio
-1.16-1.21-2.15
Net Debt / EBITDA Ratio
0.370.620.27
Net Debt / FCF Ratio
0.400.700.33
Quick Ratio
2.913.761.24
Current Ratio
3.234.001.47
Return on Equity (ROE)
--336.74%-
Return on Assets (ROA)
--140.26%-
Return on Capital Employed (ROCE)
-311.20%-193.40%-752.80%
Buyback Yield / Dilution
--24.39%-
SEC Filings: 10-K · 10-Q